Filter
980
Filtered Results: 980
Text search:
pharmaceutical
procurement
Featured
Recommendations
106
New Publications
308
Language
Document type
No document type
508
Studies & Reports
178
Guidelines
149
Strategic & Response Plan
59
Manuals
44
Fact sheets
18
Training Material
10
Situation Updates
9
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Ethiopia
57
Kenya
51
Global
34
India
33
Uganda
28
Sierra Leone
25
South Africa
25
Nigeria
23
Liberia
23
Ghana
19
Malawi
19
Tanzania
19
Nepal
17
Rwanda
17
Western and Central Europe
16
Zambia
16
Bangladesh
14
Ukraine
13
Namibia
13
Zimbabwe
12
Philippines
12
Africa
12
Lesotho
11
Eastern Europe
9
Syria
8
Cambodia
8
Senegal
7
Latin America and the Carribbean
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Botswana
6
Indonesia
6
Eswatini/ Swaziland
6
Benin
5
Cameroon
5
Burkina Faso
5
Asia
5
West and Central Africa
5
South–East Asia Region
5
East and Southern Africa
5
Haiti
4
Guinea
3
Mozambique
3
Middle East and North Africa
3
North America
3
Papua New Guinea
3
Sudan
3
Thailand
2
Albania
2
Jordan
2
Western Pacific Region
2
Lebanon
2
Yemen
2
South Sudan
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Fiji
1
Laos
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Maldives
1
Southern Africa
1
Brazil
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
493
Clinical Guidelines
57
Public Health
40
Key Resources
34
Pharmacy & Technologies
23
Women & Child Health
22
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
Pharmacy
109
AMR
94
COVID-19
65
HIV
58
TB
52
Rapid Response
26
Planetary Health
20
NTDs
19
Health Financing Toolbox
19
Conflict
16
NCDs
15
Global Health Education
13
Mental Health
12
Ebola
11
Caregiver
9
Natural Hazards
4
Polio
3
Refugee
2
Disability
2
Cholera
2
Health Financing
2
Specific Hazards
1
Zika
1
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Sector Environmental Guidelines, Full technical Update
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova.
These include:
Organized crime and illicit trafficking (including trafficking in persons, drugs, arms, illicit toba...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
